Bryan Clampitt

Mr. Bryan Clampitt

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2024 in Viruses
Verified
Journal Article
Open access
PDF file
TKThomas Leonidas Karadimas
Thomas Leonidas Karadimas
THThien Huong Huynh
Thien Huong Huynh
CCChloe Chose
Chloe Chose
GZGuston Zervoudakis
Guston Zervoudakis
BCBryan Clampitt
Bryan Clampitt
ALAlexander Lazarides
Alexander Lazarides
Primary bone malignancies, including osteosarcoma (OS), are rare but aggressive. Current OS treatment, involving surgical resection and chemotherapy, has improved survival for non-metastatic cases but remains ineffective for recurrent or metastatic OS. Oncolytic viral therapy (OVT) is a promising alternative, using naturally occurring or genetically modified viruses to selectively target and lyse cancer cells and induce a robust immune response against remaining OS cells. Various oncolytic viruses (OVs), such as adenovirus, herpes simplex virus, and measles virus, have demonstrated efficacy in preclinical OS models. Combining OVT with other therapeutics, such as chemotherapy or immunotherapy, may further improve outcomes. Despite these advances, challenges in reliability of preclinical models, safety, delivery, and immune response must be addressed to optimize OVT for clinical use. Future research should focus on refining delivery methods, exploring combination treatments, and clinical trials to ensure OVT’s efficacy and safety for OS. Overall, OVT represents a novel approach with the potential to drastically improve survival outcomes for patients with OS.

28 September 2023 in World Neurosurgery
Verified
Journal Article
Closed access
BCBryan Clampitt
Bryan Clampitt
MMMolly Monsour
Molly Monsour
MKMaryam Kazelka
Maryam Kazelka
SSSamantha Schimmel
Samantha Schimmel
DCDavide Croci
Davide Croci

14 June 2025 in World Neurosurgery
Verified
Journal Article
Open access
SSSchahin Salmanian
Schahin Salmanian
SSSamantha Schimmel
Samantha Schimmel
BCBryan Clampitt
Bryan Clampitt
MTMaya Toothman
Maya Toothman
PAPetra Allen
Petra Allen
PKPatrick Kim
Patrick Kim
Spinal stenosis is a common degenerative condition affecting quality of life. Minimally invasive surgical (MIS) techniques like tubular and endoscopic decompression are increasingly favored over open surgery, but direct comparisons remain limited. This study evaluates their relative effectiveness in terms of operative metrics, postoperative pain, complications, and hospital stay. We conducted a retrospective single-center review of 180 patients who underwent tubular (n = 101) or endoscopic (n = 79) MIS decompression for lumbar spinal stenosis between June 2021 and April 2024. Demographics, perioperative variables, and outcomes such as pain scores, infection rates, reoperations, and hospital stay were compared using standard statistical tests. Both groups had similar complication and reoperation rates. Endoscopic patients reported significantly lower immediate postoperative pain (P = 0.001) and greater pain reduction from baseline (P = 0.020). No infections occurred in the endoscopic group, compared to a 5.0% infection rate in the tubular group (P = 0.045). Endoscopic cases also showed shorter in-room to incision times (P = 0.045) and reduced closure durations (P < 0.001). Hospital stay length was comparable (P = 0.138), although complications prolonged stays in the tubular group. Both techniques are effective for MIS spinal decompression. Endoscopic surgery offers advantages in short-term outcomes, including lower infection risk, improved pain relief, and greater procedural efficiency. These findings support its growing role, although further prospective studies are warranted to refine clinical recommendations.

1 December 2025 in Journal of Spine Surgery
Verified
Journal Article
Open access
PDF file
SSSamantha Schimmel
Samantha Schimmel
CCChloe Chose
Chloe Chose
RRRichard Rivera
Richard Rivera
BCBryan Clampitt
Bryan Clampitt
SSSchahin Salmanian
Schahin Salmanian
PAPuya Alikhani
Puya Alikhani
Background: Adult spinal deformity (ASD) can result in debilitating symptoms and often necessitates surgical intervention. Postoperative complications—including thromboembolic events, proximal junctional kyphosis (PJK), pseudoarthrosis, and rod fracture—are common and can severely impact outcomes. While spinal bracing is commonly employed postoperatively, its’ clinical value remains unproven. The aim of this study was to compare complication rates, pain levels, and outcomes between patients who received thoracolumbosacral orthosis (TLSO) bracing and those who did not following ASD surgery. Methods: We conducted a retrospective review of consecutive ASD surgeries at our tertiary care center between 2016 and 2023. ASD surgery was defined as multilevel fusion involving at least 5 vertebral levels, extending from the pelvis to L2 or above. Surgical approaches included open or minimally invasive methods via different interbodies such as transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), or lateral lumbar interbody fusion (LLIF). Nine surgeons participated in the cohort. Results: Of 265 patients, 193 (73%) received TLSO bracing postoperatively. Braced patients had a significantly increased risk of rhabdomyolysis [odds ratio (OR) =9.959; P<0.001] and deep vein thrombosis (DVT) (OR =5.960; P=0.007). Long-term opioid use (≥12 months) was more common in braced patients (OR =3.895; P=0.002), and they reported higher postoperative back and leg pain (P<0.05). Bracing was not associated with a reduction in surgical complications, nor did it improve spinopelvic alignment outcomes. Conclusions: Routine bracing following ASD surgery does not reduce mechanical or surgical complications and may contribute to immobility-related morbidity and prolonged pain management. Forgoing postoperative bracing may improve patient outcomes and reduce healthcare costs. These findings support a reevaluation of routine bracing in ASD care.

20 September 2026 in Neurology International
Verified
Journal Article
Open access
PDF file
AHAtef Hulliel
Atef Hulliel
DSDana Saleh
Dana Saleh
AAAhmad Zayd Alkadri
Ahmad Zayd Alkadri
DBDavid Boughanem
David Boughanem
RCRafal Chociej
Rafal Chociej
PAPuya Alikhani
Puya Alikhani
Introduction: Lateral lumbar interbody fusion (LLIF) provides effective anterior column reconstruction while avoiding extensive posterior dissection; however, its transpsoas trajectory places the lumbar plexus at risk of neurological complications. The incidence, clinical patterns, and predictors of these events remain incompletely defined because of heterogeneous reporting across studies. Method: We performed a retrospective cohort study of consecutive adult patients undergoing transpsoas LLIF at a tertiary spine centre between 2016 and 2023. Demographic, clinical, and operative variables were collected, and postoperative neurological complications were identified from clinical documentation and imaging when available. Multivariable logistic regression was performed to determine independent predictors of transient motor weakness, acute thigh paraesthesia, and transient paraesthesia. Results: Among 545 patients, 167 (30.6%) experienced at least one neurological complication. The most common events were acute thigh paraesthesia (14.4%) and transient motor weakness (13.2%), whereas hip flexion weakness (2.1%), femoral palsy (1.3%), and psoas haematoma (1.4%) were uncommon. Obesity was independently associated with transient motor weakness (OR 1.77, 95% CI 1.06–2.93; p = 0.028). Younger age independently predicted acute thigh paraesthesia (OR 0.96 per year, 95% CI 0.94–0.99; p = 0.002) and transient paraesthesia (OR 0.97 per year, 95% CI 0.94–1.00; p = 0.049). Multilevel surgery was independently associated with acute thigh paraesthesia (OR 1.67, 95% CI 1.02–2.74; p = 0.043). Conclusions: Neurological complications following LLIF are relatively frequent but are predominantly transient sensory disturbances or temporary motor weakness. Obesity, younger age, and multilevel surgery identify patients with increased risk of specific neurological events. These findings support individualized counselling, careful surgical planning, and continued investigation into anatomical and intraoperative factors underlying LLIF-related neurological morbidity.

13 February 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
OJOrlando De Jesús
Orlando De Jesús
RTRicardo Fernández-de Thomas
Ricardo Fernández-de Thomas
CCCesar Manuel Carballo Cuello
Cesar Manuel Carballo Cuello
BCBryan Clampitt
Bryan Clampitt
Purpose: Choroid plexus papilloma (CPP) is a rare, benign intraventricular tumor that typically has an excellent long-term survival rate after gross total resection. Nevertheless, some patients develop delayed leptomeningeal dissemination (LMD) years after the initial diagnosis, a phenomenon that remains poorly understood. The authors encountered a case of CPP with delayed LMD 14 years after resection, which prompted this systematic review to identify potential risk factors. Methods: A systematic review was conducted according to PRISMA guidelines to identify CPP reports with subsequent delayed LMD. Studies of atypical CPP, choroid plexus carcinoma, or concurrent LMD at diagnosis were excluded. Extracted variables included demographics, tumor location, extent of resection, recurrence, proliferative index, and latency to dissemination. Results: Thirty patients developed delayed LMD after initial diagnosis. Seventeen patients underwent gross total resection, ten underwent subtotal resection, and three were unreported. Delayed LMD occurred with tumor recurrence in 14 patients. Histological transformation was observed in nine patients: eight progressed to aCPP and one to CPC. The extent of resection, recurrence, and tumor transformation were not significantly associated with delayed LMD. Conclusions: The pathogenesis and optimal treatment strategy of this phenomenon remain unclear. No significant risk factors for delayed LMD development in CPP were identified. Future studies incorporating molecular characterization are needed to clarify the mechanisms of LMD in patients with CPP and to improve risk stratification, underscoring the importance of lifelong surveillance and the integration of molecular profiling in clinical management.